Fantasy and science fiction book sales increased 41.3% between 2023 and 2024, as women posting on BookTok have been fueling a rise in a genre called “romantasy,” or romance fantasy. Now, Organon — ...

Shares of NYSE OGN opened at $9.60 on Friday. Organon & Co. has a twelve month low of $9.18 and a twelve month high of $23.10. The company has a 50 day moving average of $13.46 and a 200 day ...

JERSEY CITY, N.J. (AP) — JERSEY CITY, N.J. (AP) — Organon & Co. (OGN) on Thursday reported first-quarter net income of $87 million. The Jersey City, New Jersey-based company said it had net ...

Organon, a women’s health-focused pharma ... of our spans and layers and the way that our various functions work together.” Similar to Organon, Reckitt Benckiser Group is also undergoing ...

This Women’s Month, Organon, dedicated to advancing women’s health at every stage of life, is raising awareness on the preventability and treatability of heart disease, urging women to take ...

Pharmaceutical company Organon (NYSE:OGN ... semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.

Organon reported a Q3 revenue of $1.6 billion, marking a 5% growth driven by a 6% rise in its women's health franchise and a 17% surge in biosimilars. The FDA extended the review period for ...

Organon stock has endured two difficult years, the only consolation for shareholders being the rise in dividend yield. Can management reverse this trend of underperformance in 2025? Let's consider ...

Please provide your email address to receive an email when new articles are posted on . Organon is an independent global health care company dedicated to promoting women’s health. Organon will ...

Organon is broadening its presence in dermatology with a deal to acquire Dermavant, a company whose main asset is a commercialized plaque psoriasis drug that could soon expand its approval to ...